Transforming urinalysis: Faster, smarter, more precise

HUMAN Diagnostics has successfully relaunched its urinalysis portfolio, introducing cutting-edge solutions that enhance precision, efficiency, and accessibility in diagnostic testing. Unveiled at Medlab Middle East 2025 in Dubai from 3–6  February, the updated portfolio features innovative technologies designed to streamline urinalysis in diverse healthcare settings.

At the heart of this transformation are two key advancements: the HumaCombilyzer, a portable, semi-automated urine strip analyser, and the HumaVision, a state-of-the-art automated urine particle analyser powered by artificial intelligence (AI) and Digital Holographic Microscopy (DHM). These innovations ensure faster and more accurate diagnostics, improving workflows and patient outcomes worldwide.

"Urinalysis is a fundamental diagnostic tool, and with our restructured portfolio, HUMAN is setting a new standard for efficiency and accuracy in this vital field," said Dr Christine Hettmann-Dreuw, VP Marketing & Strategic Purchase at HUMAN Diagnostics. "By integrating advanced AI and user-friendly designs, we are enhancing workflows while maintaining our commitment to providing solutions that are accessible worldwide."

The HumaCombilyzer is a versatile urine test strip analyser capable of delivering rapid results for up to 14 parameters. Designed for small clinics and mobile healthcare environments, its portability and intuitive interface make it particularly suited for resource-limited settings. Meanwhile, the HumaVision is the smallest, most user-friendly urine microscope on the market. Utilising DHM and AI, it delivers precise and fully digitalised urine particle analysis in just 3–7 minutes, eliminating the need for complex sample preparation. Compared to manual microscopy, it offers a larger field of view and more reliable results.

The updated portfolio is designed to support the diagnosis of urinary tract infections, kidney conditions, and metabolic disorders such as diabetes and liver diseases. By automating key processes, these instruments significantly reduce human error, optimise laboratory workflows, and enhance diagnostic confidence.

At Medlab ME 2025, attendees had the opportunity to experience HUMAN Diagnostics' innovations firsthand. Live demonstrations at the HUMAN booth highlighted the practical benefits of these solutions, reinforcing their impact on improving diagnostic workflows and patient care on a global scale.

HUMAN Diagnostics remains committed to supporting healthcare professionals in over 160 countries with high-quality, German-engineered solutions that enhance equitable access to life-saving diagnostics.

More information online